In the first year following diagnosis, we found increased cumulative incidence risk ratios in a number of outcomes including: - Any mental, behavioural, or neurodevelopmental disorder 1.96 (1.93 - 1.99) - Postpartum depression 2.70 (2.61 - 2.79) - Eating disorders 2.06 (1.85 - 2.89) - PTSD 1.77 (1.69 - 1.86) We also saw significantly increased risk in rare but serious outcomes such as: - Wernicke's encephalopathy 2.39 (1.25 - 4.56) - Puerperal psychosis 1.80 (1.48 - 2.20) Interestingly, cases of hyperemesis gravidarum with metabolic disturbance displayed a significantly lower risk of any depression and postpartum depression compared with those without metabolic disturbance
doi: 10.1177/0148607113502674 3 OtteryFD
These symptoms can be mild to severe and may require adjustments in dosage or discontinuation of the medication
Extent of lateral internal sphincterotomy: up to the dentate line or up to the fissure apex
GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysis
BS has also shown to have an overall mortality benefit in severe obesity and has favorable effects on metabolic parameters and comorbidities such as hypertension, hyperlipidemia, metabolic syndrome, cardiovascular risk and glycemic control in diabetes